MRK vs. HIMS
MRK (Merck & Co., Inc.) and HIMS (Hims & Hers Health, Inc.) are both stocks. Both are in the Healthcare sector — MRK in Drug Manufacturers - General, HIMS in Drug Manufacturers - Specialty & Generic. Over the past 5 years, MRK returned 12.81%/yr vs 17.04%/yr for HIMS. At a 0.00 correlation, their price movements are largely independent.
Performance
MRK vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRK achieves a 13.94% return, which is significantly higher than HIMS's -17.40% return.
MRK
- 1D
- -1.42%
- 1M
- 4.97%
- YTD
- 13.94%
- 6M
- 20.60%
- 1Y
- 50.99%
- 3Y*
- 5.87%
- 5Y*
- 12.81%
- 10Y*
- 11.59%
HIMS
- 1D
- -7.10%
- 1M
- 10.64%
- YTD
- -17.40%
- 6M
- -27.92%
- 1Y
- -51.66%
- 3Y*
- 43.69%
- 5Y*
- 17.04%
- 10Y*
- —
MRK vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 13.94% | 9.79% | -6.26% | 1.01% | 49.42% | 1.75% | -7.20% | 10.65% |
HIMS Hims & Hers Health, Inc. | -17.40% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
Correlation
The correlation between MRK and HIMS is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.00 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.00 |
Fundamentals
MRK:
$294.29B
HIMS:
$6.12B
MRK:
$3.58
HIMS:
-$0.05
MRK:
4.52
HIMS:
2.78
MRK:
6.41
HIMS:
13.73
MRK:
$65.59B
HIMS:
$2.37B
MRK:
$49.79B
HIMS:
$1.70B
MRK:
$22.69B
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRK vs. HIMS — Risk / Return Rank
MRK
HIMS
MRK vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRK | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.43 | ||
| Sortino ratioReturn per unit of downside risk | +3.24 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 0.95 | +0.39 |
| Calmar ratioReturn relative to maximum drawdown | 4.49 | -0.68 | +5.17 |
| Martin ratioReturn relative to average drawdown | 11.22 | -1.10 | +12.32 |
Loading charts...
Drawdowns
MRK vs. HIMS - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.61%, smaller than the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for MRK and HIMS.
Loading charts...
Drawdown Indicators
| MRK | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.61% | -87.29% | +18.68% |
Max Drawdown (1Y)Largest decline over 1 year | -11.37% | -78.06% | +66.69% |
Max Drawdown (3Y)Largest decline over 3 years | -43.44% | -78.88% | +35.44% |
Max Drawdown (5Y)Largest decline over 5 years | -43.44% | -78.88% | +35.44% |
Max Drawdown (10Y)Largest decline over 10 years | -43.44% | — | — |
Current DrawdownCurrent decline from peak | -5.03% | -60.98% | +55.95% |
Average DrawdownAverage peak-to-trough decline | -18.83% | -43.23% | +24.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.54% | 48.06% | -43.52% |
Volatility
MRK vs. HIMS - Volatility Comparison
The current volatility for Merck & Co., Inc. (MRK) is 9.57%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 21.36%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRK | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.57% | 21.36% | -11.79% |
Volatility (6M)Calculated over the trailing 6-month period | 18.04% | 67.20% | -49.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.18% | 96.46% | -69.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.66% | 83.26% | -59.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.96% | 77.20% | -54.24% |
Dividends
MRK vs. HIMS - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 2.79%, while HIMS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 2.79% | 3.12% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% |
Financials
MRK vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MRK vs. HIMS - Profitability Comparison
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
Frequently Asked Questions
MRK and HIMS have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (21.36%) compared to MRK (9.57%). In terms of maximum drawdown, MRK dropped -68.61% vs HIMS's -87.29%.
MRK currently has the higher Sharpe Ratio (1.88 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRK and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer